New research suggests that the risk for developing dementia is significantly higher than previously estimated, and the burden ...
The risk of developing dementia may be much higher than previously thought, a study published in the journal Nature Medicine ...
Dementia, a progressive disorder that impacts memory and independence, affects millions globally. While many are aware of ...
Appropriate use criteria (AUC) for the use of amyloid and tau positron emission tomography (PET) have been issued by the ...
In a mouse study, researchers found that zolpidem (Ambien), a common sleep aid, could prevent the brain from effectively ...
A doctor who punched a dementia patient in the head and pushed his head into a pillow, has been erased from the medical ...
Leqembi's subcutaneous dosing allows Alzheimer's patients to administer weekly treatment at home in 15 seconds ... s disease ...
The FDA has accepted the BLA for lecanemab-irmb SC for weekly maintenance dosing in the treatment of early Alzheimer disease.
BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) today announced that the U.S. Food and Drug Administration (FDA) has accepted BioArctic's partner Eisai's Biologics License Application (BLA) for Leqembi ...
Discover the power of music therapy for dementia. Learn how music can reduce distress and improve well-being in institutional ...
The FDA has accepted Eisai and Biogen’s biologics license application for a monthly infusion of IV Leqembi to treat ...
Researchers at New York’s Mount Sinai Hospital have developed a cutting-edge AI-powered algorithm which could aid in the ...